Gritstone bio (GRTS) News Today → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free GRTS Stock Alerts $0.75 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 2:12 PM | marketbeat.comGritstone bio, Inc. (NASDAQ:GRTS) Short Interest UpdateGritstone bio, Inc. (NASDAQ:GRTS - Get Free Report) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 15,110,000 shares, a growth of 18.0% from the April 15th total of 12,800,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is currently 5.3 days. Approximately 15.4% of the company's stock are sold short.May 16 at 1:46 AM | americanbankingnews.comHC Wainwright Comments on Gritstone bio, Inc.'s Q2 2024 Earnings (NASDAQ:GRTS)May 15 at 7:03 AM | marketbeat.comHC Wainwright Weighs in on Gritstone bio, Inc.'s Q2 2024 Earnings (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Research analysts at HC Wainwright increased their Q2 2024 earnings per share (EPS) estimates for Gritstone bio in a report issued on Monday, May 13th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings of ($0.28) perMay 15 at 3:08 AM | americanbankingnews.comGritstone bio (NASDAQ:GRTS) Given New $4.00 Price Target at HC WainwrightMay 13 at 10:24 AM | markets.businessinsider.comBeyond The Numbers: 4 Analysts Discuss Gritstone Bio StockMay 13 at 8:20 AM | marketbeat.comHC Wainwright Cuts Gritstone bio (NASDAQ:GRTS) Price Target to $4.00HC Wainwright cut their price target on Gritstone bio from $7.00 to $4.00 and set a "buy" rating on the stock in a report on Monday.May 11, 2024 | marketbeat.comGritstone bio (NASDAQ:GRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPSGritstone bio (NASDAQ:GRTS - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.34) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by ($0.04). Gritstone bio had a negative net margin of 926.13% and a negative return on equity of 184.66%. The business had revenue of $1.74 million for the quarter, compared to the consensus estimate of $5.90 million. During the same period last year, the firm posted ($0.30) EPS.May 11, 2024 | finance.yahoo.comGritstone bio First Quarter 2024 Earnings: Misses ExpectationsMay 9, 2024 | msn.comGritstone bio GAAP EPS of -$0.34 misses by $0.02, revenue of $1.74M misses by $1.11MMay 9, 2024 | finance.yahoo.comGritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 8, 2024 | americanbankingnews.comGritstone bio (GRTS) Scheduled to Post Quarterly Earnings on ThursdayMay 3, 2024 | marketbeat.comGritstone bio (GRTS) Set to Announce Earnings on ThursdayGritstone bio (NASDAQ:GRTS) will be releasing earnings after the market closes on Thursday, May 9, Zacks reports.May 2, 2024 | globenewswire.comGritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024April 29, 2024 | globenewswire.comGritstone bio Announces Appointment of Stephen Webster to its Board of DirectorsApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSApril 17, 2024 | marketbeat.comQ2 2024 Earnings Estimate for Gritstone bio, Inc. Issued By B. Riley (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Equities researchers at B. Riley issued their Q2 2024 earnings estimates for Gritstone bio in a research report issued to clients and investors on Tuesday, April 16th. B. Riley analyst M. Mamtani expects that the company will post earnings per shaApril 15, 2024 | finance.yahoo.comNature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)April 15, 2024 | globenewswire.comNature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)April 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSApril 10, 2024 | stockhouse.comGritstone bio Presents Improvements to EDGE(TM) Platform at AACR 2024April 8, 2024 | markets.businessinsider.comBuy Rating Affirmed: Gritstone Oncology’s Promising Growth and Technological AdvancementsApril 8, 2024 | finance.yahoo.comGritstone bio Presents Improvements to EDGE™ Platform at AACR 2024April 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSApril 3, 2024 | benzinga.comGritstone Bio Stock (NASDAQ:GRTS), Quotes and News SummaryApril 2, 2024 | markets.businessinsider.comNasdaq Down Over 1%; VivoPower International Shares Spike HigherApril 2, 2024 | msn.comWhat's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?April 2, 2024 | marketbeat.comGritstone bio (NASDAQ:GRTS) PT Raised to $5.00 at JMP SecuritiesJMP Securities lifted their price target on Gritstone bio from $4.00 to $5.00 and gave the company a "market outperform" rating in a research note on Tuesday.April 2, 2024 | investorplace.comWhy Are Health Insurance Stocks HUM, UNH, CI Down Today?April 2, 2024 | marketwatch.comGritstone Bio Shares Drop 33% After Public Offering PricesApril 2, 2024 | investorplace.comWhy Is Gritstone Bio (GRTS) Stock Down 44% Today?April 2, 2024 | marketbeat.comGritstone bio, Inc. (NASDAQ:GRTS) Short Interest Up 7.3% in MarchGritstone bio, Inc. (NASDAQ:GRTS - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 8,820,000 shares, a growth of 7.3% from the February 29th total of 8,220,000 shares. Approximately 9.9% of the company's stock are short sold. Based on an average trading volume of 2,050,000 shares, the short-interest ratio is currently 4.3 days.April 1, 2024 | globenewswire.comGritstone bio Announces Pricing of $32.5 Million Underwritten Public OfferingApril 1, 2024 | msn.comGritstone stock plunges 35% on mixed Phase 2 data, public offeringApril 1, 2024 | globenewswire.comGritstone bio Announces Proposed Public OfferingApril 1, 2024 | globenewswire.comGritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)March 28, 2024 | seekingalpha.comGRTS Gritstone bio, Inc.March 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSMarch 18, 2024 | msn.comDo Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?March 11, 2024 | marketbeat.comResearch Analysts Set Expectations for Gritstone bio, Inc.'s Q1 2024 Earnings (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Investment analysts at HC Wainwright upped their Q1 2024 earnings per share (EPS) estimates for Gritstone bio in a research note issued to investors on Wednesday, March 6th. HC Wainwright analyst S. Lee now forecasts that the company will post earMarch 8, 2024 | finance.yahoo.comGritstone bio, Inc. (NASDAQ:GRTS) Just Reported And Analysts Have Been Cutting Their EstimatesMarch 8, 2024 | marketbeat.comFY2028 Earnings Forecast for Gritstone bio, Inc. Issued By HC Wainwright (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Equities research analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for shares of Gritstone bio in a report issued on Wednesday, March 6th. HC Wainwright analyst S. Lee anticipates that the company will post earningsMarch 7, 2024 | finance.yahoo.comGritstone Bio Inc (GRTS) Reports Fiscal Year 2023 Financial Results and Corporate UpdatesMarch 7, 2024 | finance.yahoo.comGritstone bio Full Year 2023 Earnings: Beats ExpectationsMarch 6, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Gritstone bio (NASDAQ:GRTS)HC Wainwright restated a "buy" rating and set a $7.00 price target on shares of Gritstone bio in a research note on Wednesday.March 5, 2024 | globenewswire.comGritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesMarch 5, 2024 | finance.yahoo.comGRTS Apr 2024 0.500 putMarch 5, 2024 | finance.yahoo.comGRTS Aug 2024 0.500 putMarch 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSMarch 1, 2024 | benzinga.comWhy Is Gritstone Bio Stock Trading Lower?March 1, 2024 | bizjournals.comDomino effect around next-generation Covid vaccine trial leads Gritstone to cut 40% of staff Get Gritstone bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. GRTS Media Mentions By Week GRTS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRTS News Sentiment▼-0.160.55▲Average Medical News Sentiment GRTS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRTS Articles This Week▼162▲GRTS Articles Average Week Get Gritstone bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OTLK News Today BLUE News Today SGMO News Today LIFE News Today OMGA News Today PASG News Today VIGL News Today CRIS News Today ALVR News Today CVM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRTS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gritstone bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
